Active substances
Bupivacaine + Epinephrine
- US FDA 15
- Health Canada 5
- NHS prices 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.25%;0.0091MG/ML; 0.5%;0.0091MG/ML | injectable · injection | HOSPIRA | Prescription | 3 Oct 1972 |
| MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.5%;0.0091MG/ML; 0.75%;0.0091MG/ML; 0.25%;0.0091MG/ML | injectable · injection | HOSPIRA | Prescription | 3 Oct 1972 |
| SENSORCAINE | 0.5%;0.0091MG/ML; 0.75%;0.0091MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 30 Dec 1981 |
| SENSORCAINE | 0.25%;0.0091MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 13 Oct 1987 |
| SENSORCAINE | 0.25%;0.0091MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 13 Oct 1987 |
| SENSORCAINE | 0.5%;0.0091MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 13 Oct 1987 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.25%;0.005MG/ML | injectable · injection | HOSPIRA | Prescription | 16 Jun 1988 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.25%;0.005MG/ML | injectable · injection | HOSPIRA | Prescription | 16 Jun 1988 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.5%;0.005MG/ML | injectable · injection | HOSPIRA | Prescription | 16 Jun 1988 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.5%;0.005MG/ML | injectable · injection | HOSPIRA | Prescription | 16 Jun 1988 |
| VIVACAINE | 0.5%;0.0091MG/ML | injectable · injection | SEPTODONT | Prescription | 27 Sep 2006 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.5%;0.0091MG/ML | injectable · injection | HOSPIRA | Discontinued | 13 Jul 1983 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.25%;0.005MG/ML | injectable · injection | HOSPIRA | Discontinued | 16 Jun 1988 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.5%;0.005MG/ML | injectable · injection | HOSPIRA | Discontinued | 16 Jun 1988 |
| BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 0.75%;0.005MG/ML | injectable · injection | HOSPIRA | Discontinued | 16 Jun 1988 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| MARCAINE | 02474247 | 0.0091 MG / ML; 5 MG / ML | SOLUTION · BLOCK/INFILTRATION | SEPTODONT INC |
| MARCAINE E | 02241915 | 0.182 MG / 20 ML; 50 MG / 20 ML | SOLUTION · BLOCK/INFILTRATION; EPIDURAL | PFIZER CANADA ULC |
| MARCAINE E | 02241916 | 100 MG / 20 ML; 0.182 MG / 20 ML | SOLUTION · EPIDURAL; BLOCK/INFILTRATION | PFIZER CANADA ULC |
| SENSORCAINE WITH EPINEPHRINE | 01976184 | 5 MCG / ML; 2.5 MG / ML | SOLUTION · EPIDURAL; BLOCK/INFILTRATION | ASPEN PHARMACARE CANADA INC. |
| SENSORCAINE WITH EPINEPHRINE | 01976206 | 5 MCG / ML; 5 MG / ML | SOLUTION · BLOCK/INFILTRATION; EPIDURAL | ASPEN PHARMACARE CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Bupivacaine 25mg/10ml (0.25%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | £46.00 | 10 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Bupivacaine 50mg/10ml (0.5%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | £51.75 | 10 ampoule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.